COL 195

Drug Profile

COL 195

Alternative Names: COL-195; Hydrocodone DETERx® - Collegium Pharmaceutical

Latest Information Update: 24 Jun 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Collegium Pharmaceutical
  • Class Analgesics; Antitussives; Morphinans; Opioid analgesics; Opioid peptides; Small molecules
  • Mechanism of Action Opioid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Pain

Most Recent Events

  • 22 Jun 2016 Topline pharmacokinetics data from a clinical trial in Pain released by Collegium Pharmaceutical
  • 21 Jan 2016 US FDA approves IND application for Hydrocodone DETERx® in Chronic pain
  • 01 Jan 2016 Phase-I/II clinical trials in Pain in USA (PO) (Collegium Form 10-K, March 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top